Esperion Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLACKROCK, INC. | 05/02/2025 | 14.49 M | $20.87 M | 1.81% | 7.39% |
VANGUARD GROUP INC | 05/09/2025 | 11.49 M | $16.54 M | -1.95% | 5.86% |
WASATCH ADVISORS LP | 05/15/2025 | 10.93 M | $15.74 M | -55.35% | 5.57% |
BELLEVUE GROUP AG | 05/14/2025 | 9.69 M | $13.96 M | -2.51% | 4.94% |
TWO SEAS CAPITAL LP | 05/15/2025 | 6.93 M | $9.98 M | 11.23% | 3.53% |
MORGAN STANLEY | 05/15/2025 | 6.59 M | $9.48 M | 4.39% | 3.36% |
STATE STREET CORP | 05/15/2025 | 4.55 M | $6.55 M | 0.98% | 2.32% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 4.45 M | $6.40 M | 2.45% | 2.27% |
MARSHALL WACE, LLP | 05/15/2025 | 3.63 M | $5.23 M | 100.00% | 1.85% |
05/12/2025 | 3.09 M | $4.45 M | 100.00% | 1.57% | |
INDABA CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 3.00 M | $4.32 M | 0.00% | 1.53% |
TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 2.73 M | $3.93 M | -22.85% | 1.39% |
TWO SIGMA ADVISERS, LP | 05/15/2025 | 2.53 M | $3.64 M | -30.12% | 1.29% |
CITADEL ADVISORS LLC | 05/15/2025 | 2.09 M | $3.01 M | 19.18% | 1.07% |
PENDERFUND CAPITAL MANAGEMENT LTD. | 05/15/2025 | 2.00 M | $4.14 M | 100.00% | 1.02% |
JPMORGAN CHASE & CO | 05/12/2025 | 1.92 M | $2.77 M | -21.70% | 0.98% |
NORTHERN TRUST CORP | 05/13/2025 | 1.54 M | $2.22 M | -0.07% | 0.78% |
GOLDMAN SACHS GROUP INC | 05/16/2025 | 1.53 M | $2.20 M | -44.53% | 0.78% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 1.53 M | $2.20 M | -6.30% | 0.78% |
WOODLINE PARTNERS LP | 05/15/2025 | 1.50 M | $2.17 M | 0.00% | 0.77% |
WELLS FARGO & COMPANY/MN | 05/13/2025 | 1.22 M | $1.75 M | 1,023.18% | 0.62% |
RHENMAN & PARTNERS ASSET MANAGEMENT AB | 05/14/2025 | 1.07 M | $1.54 M | -44.31% | 0.54% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 961.04 K | $1.38 M | 15.80% | 0.49% |
SQUAREPOINT OPS LLC | 05/15/2025 | 877.41 K | $1.26 M | 158.80% | 0.45% |
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 05/12/2025 | 822.62 K | $1.18 M | -11.74% | 0.42% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 762.63 K | $1.10 M | 4.72% | 0.39% |
WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 761.98 K | $1.10 M | 36.00% | 0.39% |
HRT FINANCIAL LP | 05/15/2025 | 669.83 K | $964.00 K | 19.50% | 0.34% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 554.22 K | $798.07 K | 0.00% | 0.28% |
GRAHAM CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 487.74 K | $702.34 K | 153.48% | 0.25% |
DIAMETRIC CAPITAL, LP | 05/14/2025 | 430.18 K | $619.45 K | 21.52% | 0.22% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 415.14 K | $597.80 K | -2.90% | 0.21% |
CITADEL ADVISORS LLC | 05/15/2025 | 396.40 K | $570.82 K | -35.68% | 0.20% |
SUMMIT WEALTH GROUP, LLC | 05/02/2025 | 293.00 K | $422.00 K | 86.62% | 0.15% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 282.10 K | $406.22 K | -41.68% | 0.14% |
D. E. SHAW & CO., INC. | 05/15/2025 | 275.71 K | $397.02 K | 9.59% | 0.14% |
BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 271.61 K | $391.12 K | 77.28% | 0.14% |
INVESCO LTD. | 05/12/2025 | 255.48 K | $367.89 K | 161.14% | 0.13% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 05/12/2025 | 254.27 K | $366.14 K | 0.00% | 0.13% |
BARCLAYS PLC | 05/15/2025 | 236.13 K | $340.00 K | -34.27% | 0.12% |
RHUMBLINE ADVISERS | 05/29/2025 | 236.03 K | $339.87 K | -4.41% | 0.12% |
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 05/15/2025 | 222.48 K | $320.37 K | 0.00% | 0.11% |
NJ STATE EMPLOYEES DEFERRED COMPENSATION PLAN | 05/09/2025 | 195.13 K | $280.98 K | 0.00% | 0.10% |
CITIGROUP INC | 05/12/2025 | 186.65 K | $268.77 K | -2.85% | 0.10% |
PENTWATER CAPITAL MANAGEMENT LP | 05/15/2025 | 181.29 K | $261.06 K | 0.00% | 0.09% |
PRELUDE CAPITAL MANAGEMENT, LLC | 05/15/2025 | 168.31 K | $242.36 K | 40.64% | 0.09% |
ALLIANCEBERNSTEIN L.P. | 05/15/2025 | 159.26 K | $229.33 K | 0.00% | 0.08% |
GROUP ONE TRADING, L.P. | 05/14/2025 | 149.72 K | $215.60 K | 54.14% | 0.08% |
SIMPLEX TRADING, LLC | 05/12/2025 | 146.74 K | $211.00 K | 100.00% | 0.07% |
QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2025 | 143.54 K | $206.69 K | -37.25% | 0.07% |
Esperion Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 260 institutional investors and hedge funds held shares of Esperion Therapeutics, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 14.49 M
VANGUARD GROUP INC: 11.49 M
WASATCH ADVISORS LP: 10.93 M
Bellevue Group AG: 9.69 M
Two Seas Capital LP: 6.93 M
MORGAN STANLEY: 6.59 M
57.86% of Esperion Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 136.18 M shares in the last 24 months. This purchase volume represents approximately $115.72 M in transactions.